Immunization News and Research

RSS

Immunization with VLP vaccine results in functional, protective immune responses against RSV

Novavax, and scientists at the University of Massachusetts Medical School, led by Dr. Trudy Morrison, published in the January 2011 issue of The Journal of Virology, a report indicating that a novel virus-like particle vaccine candidate against respiratory syncytial virus (RSV) protects mice from a live virus challenge.

23 Dec 2010

Pfizer seeks FDA and EMA approval for expanded use of Prevnar 13 for pneumococcal disease

Pfizer Inc today announced that it has submitted supplemental applications to both the United States Food and Drug Administration (FDA) and the European Medicines Agency (EMA) to expand the use of Prevnar 13® (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein]) to adults 50 years of age and older for the prevention of pneumococcal disease caused by the 13 serotypes contained in the vaccine.

23 Dec 2010

Merck announces FDA approval for GARDASIL against HPV-related anal cancer

Merck, known as MSD outside the United States and Canada, announced today that the U.S. Food and Drug Administration (FDA) has approved GARDASIL® [Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant] for the prevention of anal cancer caused by human papillomavirus (HPV) types 16 and 18 and for the prevention of anal intraepithelial neoplasia (AIN) grades 1, 2 and 3 (anal dysplasias and precancerous lesions) caused by HPV types 6, 11, 16 and 18, in males and females 9 through 26 years of age.

23 Dec 2010

FDA approves Gardasil for prevention of anal cancer

The U.S. Food and Drug Administration today approved the vaccine Gardasil for the prevention of anal cancer and associated precancerous lesions due to human papillomavirus (HPV) types 6, 11, 16, and 18 in people ages 9 through 26 years.

23 Dec 2010

Biovest issues FAQ update on BiovaxID personalized cancer vaccine

Biovest International, Inc. today issued the following update in the form of a "Frequently Asked Questions" report in response to the high volume of inquiries received following the Company's recent presentation at the 2010 American Society of Hematology Annual Meeting (ASH 2010) in Orlando, Florida.

21 Dec 2010

AAPD pediatric oral health experts partner with text4baby to provide information to pregnant women, new moms

The American Academy of Pediatric Dentistry (AAPD), the recognized leader in children's oral health, announced today an outreach partnership with the text4baby program. The AAPD's leading pediatric oral health experts will work closely with text4baby in the dissemination of information to pregnant women and new moms about children's oral health care.

20 Dec 2010

Walgreens partners with HHS to provide over $10M worth of flu shots for people without adequate health insurance

Walgreens and the U.S. Department of Health and Human Services (HHS) are teaming up in an effort to make 2011 a healthier New Year for those without adequate health insurance.

20 Dec 2010

GAVI Alliance launches pneumonia vaccine project in Nicaragua

"A new vaccine against the most deadly forms of pneumonia, one of the world's biggest killers of children, [was] launched in Nicaragua [on Sunday] as part of an effort to prevent 700,000 deaths in poorer countries by 2015," Reuters reports (Kelland, 12/10).

14 Dec 2010

Intercell to stop further development of Travelers' Diarrhea Vaccine Patch

Intercell AG announced today preliminary clinical results on its investigational Travelers' Diarrhea (TD) Vaccine Patch program and the decision not to pursue further the development of this vaccine candidate. The decision was made following the receipt of results of its randomized and placebo-controlled Phase III study (ELT301) with 2036 travelers from Europe to Mexico and Guatemala as well as the pilot efficacy Phase II trial (ELT209) with 723 travelers from Europe to India.

13 Dec 2010

Prevenar 13 launched in first childhood immunization program for PD in Nicaragua

Pfizer Inc. announced that Prevenar 13 (Pneumococcal polysaccharide conjugate vaccine [13-valent, adsorbed]) was introduced into the first childhood immunization program for pneumococcal disease (PD) in the developing world under the auspices of the Advance Market Commitment (AMC) when Nicaragua launched its program today. The AMC is an innovative program which involves private-public partnerships to help make newer vaccines available on a sustainable, affordable and accelerated basis to the least developed countries.

13 Dec 2010

News outlets report on polio outbreaks in Central, East Africa

"Bad immunisation strategy has been blamed for an outbreak of polio, which has killed nearly 200 and is believed to have caused paralysis in more than 2,000 others across Angola, Congo and the Democratic Republic of the Congo," the Mail & Guardian writes in a story examining the emergence of the disease in the three countries and efforts to control it.

10 Dec 2010

New software predicts key information about nasal insulin treatment regimens in type 1 diabetes

A La Jolla Institute team, led by leading type 1 diabetes researcher Matthias von Herrath, M.D., has demonstrated the effectiveness of a recently developed computer model in predicting key information about nasal insulin treatment regimens in type 1 (juvenile) diabetes. Development of the software, the Type 1 Diabetes PhysioLab- Platform, was funded through the peer-reviewed grant program of the American Diabetes Association.

9 Dec 2010

Annual survey ranks states on health, health care

An annual survey ranks state's overall health and gives snap shots of specific measures including crime, air pollution and smoking rates.

9 Dec 2010

Campaign to inoculate millions across Africa against meningitis kicks off in Burkina Faso

On Monday, a campaign started in Burkina Faso to "inoculate tens of millions of West Africans with a new vaccine in what scientists hope will be the beginning of the end of ravaging meningitis epidemics" across the continent, the New York Times reports.

7 Dec 2010

Guardian examines difficulty of delivering polio vaccines in war-torn parts of Africa, like DRC

UNICEF is calling for an immediate ceasefire in the Democratic Republic of Congo (DRC) so that polio vaccinators can access millions of children in an effort to beat back the re-emergence of the disease in several African nations, the Guardian reports. "We are calling on all parties to the conflict to respect the vaccination days and cease fighting," said Pierrette Vu Thi, UNICEF's representative in the DRC. "All children have the same right to health," Vu Thi said.

7 Dec 2010

FDA accepts for review Bristol-Myers Squibb's ORENCIA sBLA for severe RA

Bristol-Myers Squibb Company today announced that the U.S. Food and Drug Administration (FDA) has accepted for review a supplemental Biologics License Application (sBLA) for the subcutaneous formulation of ORENCIA® (abatacept), a treatment for adult patients with moderate to severe rheumatoid arthritis (RA) administered through an injection into the skin. Bristol-Myers Squibb submitted the sBLA to the FDA for the subcutaneous formulation of ORENCIA and received confirmation of its receipt on October 4, 2010.

7 Dec 2010

One shot, cheap meningitis vaccine now available in Africa

As a boon to millions of children who die of meningitis, a cheap new vaccine for bacterial meningitis debuted today with the launching of an immunization drive in the West African country of Burkina Faso, in the first stage of an effort that could rid sub-Saharan Africa of the primary cause of meningitis, the World Health Organization (WHO) announced.

6 Dec 2010

UNICEF spearheads polio immunization campaign across Abkhazia

UNICEF, the Abkhaz authorities and the European Union have left no stone unturned in their efforts to keep the region polio-free. In the first round of the polio immunization campaign that began here in November, 98 percent of all children up to 17 years of age were vaccinated.

4 Dec 2010

Wide-scale study of flu vaccine's effectiveness in European children needed

A wide-scale study of the effectiveness of flu vaccine in children is needed in Europe to fully assess the benefits, not only in keeping the kids from getting sick, but limiting the spread of flu to adults.

4 Dec 2010

NFID supports CDC's National Influenza Vaccination Week

The National Foundation for Infectious Diseases supports the Centers for Disease Control and Prevention's annual observance of National Influenza Vaccination Week to communicate the importance and availability of influenza vaccination into the winter months and beyond. It is critical that physicians and patients, especially parents of pediatric patients, remain vigilant about flu protection this and every year.

4 Dec 2010

Immunization News and Research

Immunization with VLP vaccine results in functional, protective immune responses against RSV

Pfizer seeks FDA and EMA approval for expanded use of Prevnar 13 for pneumococcal disease

Merck announces FDA approval for GARDASIL against HPV-related anal cancer

FDA approves Gardasil for prevention of anal cancer

Biovest issues FAQ update on BiovaxID personalized cancer vaccine

AAPD pediatric oral health experts partner with text4baby to provide information to pregnant women, new moms

Walgreens partners with HHS to provide over $10M worth of flu shots for people without adequate health insurance

GAVI Alliance launches pneumonia vaccine project in Nicaragua

Intercell to stop further development of Travelers' Diarrhea Vaccine Patch

Prevenar 13 launched in first childhood immunization program for PD in Nicaragua

News outlets report on polio outbreaks in Central, East Africa

New software predicts key information about nasal insulin treatment regimens in type 1 diabetes

Annual survey ranks states on health, health care

Campaign to inoculate millions across Africa against meningitis kicks off in Burkina Faso

Guardian examines difficulty of delivering polio vaccines in war-torn parts of Africa, like DRC

FDA accepts for review Bristol-Myers Squibb's ORENCIA sBLA for severe RA

One shot, cheap meningitis vaccine now available in Africa

UNICEF spearheads polio immunization campaign across Abkhazia

Wide-scale study of flu vaccine's effectiveness in European children needed

NFID supports CDC's National Influenza Vaccination Week

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News